Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Metastatic or Unresectable Pancreatic Cancer
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy, such as gemcitabine and capecitabine, work in
different ways to stop the growth of tumor cells, either by killing the cells or by stopping
them from dividing. Bevacizumab may stop the growth of tumor cells by stopping blood flow to
the tumor. Giving gemcitabine and capecitabine together with bevacizumab may kill more tumor
cells.
PURPOSE: This phase II trial is studying how well giving gemcitabine and capecitabine
together with bevacizumab works in treating patients with metastatic or unresectable
pancreatic cancer.